The composition of the Board reflects an emphasis on engagement and collaboration between the Capital Region of Denmark, other hospitals in the Region, municipalities and educational institutions.
The board of directors comprises of:
 | |
Svend Hartling (chairman)
Capital Region of Denmark
|
 | |
Klaus Lunding
Herlev and Gentofte Hospital
|
 | |
Jannik Hilsted
Novo Nordisk Foundation
|
 | |
Ulla Wever
University of Copenhagen
|
 | |
Katja Kayser
Municipality of Copenhagen
|
 | |
Marianne Baun
SDCC
|
 | |
Sophie Hindkjær
User at SDCC
|
 | |
Christian Collin
User at SDCC
|
The Board of Directors operates within the framework and performance contract established between the Capital Region of Denmark and the Novo Nordisk Foundation, including any other future collaboration partners. Ownership and day-to-day operations are the responsibility of the Capital Region of Denmark.
Board meetings 2019
8 March 2019 - Hagedorn (Gentofte)
21 June 2019 - Hagedorn (Gentofte)
13. September 2019 - Hagedorn (Gentofte)
13 December 2019 – Hagedorn (Gentofte)